ANXA5 and neoplasm: In addition, it has been shown that the binding of AnxA5 to PS+ apoptotic cells can modulate the PS-mediated immunosuppressive clearance, thereby increasing the immunogenicity of apoptotic cells, including irradiated, apoptotic-tumor cells20–23.